Updated December 2025
In the second subgroup with an FIB-4 score 1.3 or aged 65 years with an FIB-4 score 2.0, the primary MACE endpoint occurred in 140 of 1,833 patients (7.6%) in the semaglutide group and in 176 of 1,831 patients (9.6%) in the placebo group (HR 0.79
The choice between oral and injectable therapy is not straightforward
This article examines the evidence and practical guidance for patients with Hashimoto's thyroiditis considering or currently taking GLP-1 receptor agonists
Common side effects of semaglutide can include low blood sugar, especially if you dont eat enough after taking the injection for diabetes 2, upset stomach, headache, dizziness, heartburn, nausea, and vomiting
Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA